Excelsior Biopharma Inc.
6496
Rank in Stocks
#24324
Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei,... Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei, Taiwan, functions as a pharmaceutical enterprise with a global market presence, encompassing Taiwan, China, and other international regions. The company offers a comprehensive range of healthcare solutions, including prescription and over-the-counter medications, medical devices, nutritional supplements, and various medical supplies. Excelsior addresses numerous therapeutic areas such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, otorhinolaryngology, and infectious disease management. Its product line also features specialized diagnostic kits under the Actim brand for identifying conditions like influenza virus, fecal occult blood, acute pancreatitis, and for assessing preterm or full-week delivery and early membrane rupture. Moreover, the company provides oral hygiene products, including toothpaste, mouthwash, and gels, under the Oral7 name. Beyond product sales, Excelsior is involved in the import and export of active pharmaceutical ingredients, as well as engaging in technological research, facilitating pharmaceutical technology transfer, and participating in collaborative development and improvement initiatives. The company adopted its current name, Excelsior Biopharma Inc., in June 2003, having previously been known as Excelsior Enterprise Co., Ltd.
Share Price
$0.73315123
Last synced: 2026-11-10
Market Cap
$34.07M
Change (1 day)
0.84%
Change (1 year)
-22.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Excelsior Biopharma Inc. (6496)
Category
Healthcare
Operating Margin for Excelsior Biopharma Inc. (6496)
Operating Margin as of November 2026 TTM: -21.31%
According to Excelsior Biopharma Inc.'s latest financial reports, its current operating margin (TTM) is -21.31%. At the end of 2025 the company had an operating margin of -19.39%.
Operating Margin history for Excelsior Biopharma Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -21.31% | 9.90% |
| 2025 | -19.39% | 112.38% |
| 2024 | -9.13% | -13.13% |
| 2023 | -10.51% | 178.78% |
| 2022 | -3.77% | 4,612.50% |
| 2021 | -0.08% | -102.47% |
| 2020 | 3.24% | -42.45% |
| 2019 | 5.63% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.91% |
DE
|
|
| 19.68% | -100.92% |
DE
|
|
| 13.26% | -100.62% |
JP
|
|
| 17.08% | -100.80% |
CH
|
|
| 14.92% | -100.70% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Excelsior Biopharma Inc.'s operating margin
What is Excelsior Biopharma Inc.'s operating margin?
Excelsior Biopharma Inc.'s operating margin is -21.31%, as of Nov 2026.
What was Excelsior Biopharma Inc.'s operating margin in 2025?
In 2025, Excelsior Biopharma Inc.'s operating margin was -19.39%, compared with -9.13% in 2024.
How has Excelsior Biopharma Inc.'s operating margin changed since 2020?
From 2020 to 2025, Excelsior Biopharma Inc.'s operating margin was highest in 2020 (3.24%) and lowest in 2025 (-19.39%).
How does Excelsior Biopharma Inc.'s operating margin compare with similar companies?
Excelsior Biopharma Inc.'s operating margin (-21.31%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.